For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place ...

Roche (OTCQX:RHHBY) subsidiary Genentech announced on Thursday that Xofluza, an FDA-approved flu antiviral, achieved its ...

The recent decision to merge Genentech’s two cancer departments was made for “scientific reasons,” executives explained to ...

AstraZeneca's Imfinzi was used before and after surgery in a clinical trial of patients with muscle-invasive bladder cancer — ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Genentech’s newly approved multiple sclerosis (MS) injection takes about 10 minutes to administer, dramatically reducing the ...

Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what its prospects are for the next ...

All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...

Genentech has received Food and Drug Administration approval for its treatment of certain types of lung, liver, skin and soft tissue cancer in adults.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results of the Phase III CENTERSTONE study of Xofluza ® (baloxavir marboxil), an antiviral, ...

According to DelveInsight's estimates, in the 7MM, the total incident cases of aGvHD for Grade B, Grade C, and Grade D were around 6,000, 3,000, and 2000 , respectively, in 2023, which are expected to ...